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ABSTRACT 
 
Tumor Angiogenesis, O2 Saturation, Glucose and Amino Acid Metabolisms Study Using 
Functional Imaging. (May 2008) 
Xueyi Xie, B.S., Qingdao University; 
M.S., University of North Texas 
Chair of Advisory Committee: Dr. Georghe Stoica 
 
This research is primarily focused on the study of tumors in experimental animal models  
using functional imaging in the presence of various contrast agents. The study of 
malignant tumor angiogenesis, oxygen saturation, glucose and amino acid metabolisms 
will lead to better methods for cancer detection as well as diagnosing and managing 
cancer. Non invasive in vivo diagnostic imaging technique is an area of great clinical 
interest in present days. In this study, noninvasive in vivo photoacoustic tomography and 
conventional fluorescence imaging together with multiphoton microscopic tomography 
were implemented to study the malignant tumor morphology and physiology. Tumor 
structure and angiogenesis were successfully imaged by photoacoustic tomography and 
conventional fluorescence imaging. The important malignant tumor cellular parameters 
such as oxygen saturation and αvβ3 integrin concentration were measured in living small 
animals (rodents) using the novel photoacoustic tomography technique. By 
implementing multiphoton microscopy using Cy3.5 NHS ester contrast agent, tumor 
amino acid metabolism was successfully studied in cell culture. This method will at least 
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give you a relative concentration map of amino acid in cells. Non invasive in vivo 
imaging can be achieved by modifying the current multiphoton imaging setup.  
A new method for studying amino acid and glucose metabolisms of tumor cells using 
multiphoton imaging was developed.  
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CHAPTER I  
INTRODUCTION  
 
Tumor or tumour (via Old French tumour from Latin tumor "swelling") is an abnormal 
growth or mass of tissue. A tumor can be either malignant or benign. Nearly all tumors 
are examples of neoplasia, although certain developmental malformations 
or inflammatory masses may occasionally be referred to as tumors. Neoplastic tumors 
are caused by mutations in DNA of cells, which interfere with a cell's ability to regulate 
and limit cell division. The main focus of this research is using molecular functional 
imaging to study some of the most important aspects of tumor morphology and 
hysiology. 
T) 
and positron emission tomography (PET) have been developed as molecular imaging  
p
 
Molecular imaging is the characterization and measurement of biological processes at 
the cellular and molecular level in live animals. The study of molecular imaging will 
lead to better methods for studying complex disease pathways, diagnosing disease at the 
earliest causative stages. Usually, molecular imaging involves detection of injected 
exogenous contrast agents such as targeted compounds with fluorescent molecules, 
radioactive atoms or paramagnetic ions that are visible to the imaging systems. The 
optical and radiologic imaging modalities such as magnetic resonance imaging (MRI), 
computed tomography (CT), single photon emission computed tomography (SPEC
                                                
This dissertation follows the style and format of Optics Letters. 
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tools for biologist to non-invasively study effects of diseases. Optical imaging 
techniques have been successfully utilized in whole small animal molecular imaging 
using near-infrared (NIR) light which can penetrate deeper in the tissue as compared to 
visible light because NIR light has longer wavelengths, but its high sensitivity and 
specificity are offset by poor spatial resolution and relatively limited imaging depth. On 
the contrary, nuclear imaging has the ability to measure radioactivity concentrations with 
the exquisite sensitivity in deep tissues. However, it involves ionizing radiation whose 
radioactive decay can’t be controlled. In addition, there is always non-specific 
background signal present in an image due to non-specific binding of radiotracers, 
residual radiotracer in the circulation and routes of excretion. Photoacoustic imaging 
technique is utilized to avoid the drawbacks mentioned above.  
 
Tumor angiogenesis is the proliferation of a network of blood vessels that penetrates into 
cancerous growths, supplying nutrients and oxygen and removing waste products. 
Tumor angiogenesis actually starts with cancerous tumor cells releasing molecules that 
send signals to surrounding normal host tissue. This signaling activates certain genes in 
the host tissue that, in turn, make proteins to encourage growth of new blood vessels.  
 
During the early years, cancer researchers believed that the blood supply reached tumors 
simply because pre-existing blood vessels dilated. But in 1960’s, experiments showed 
that angiogenesis is necessary for cancerous tumors to keep growing and spreading. This 
eventually led to the discovery of angiogenesis inhibitors which are used for the cancer 
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therapy now a day. The imaging of tumor angiogenesis is important for understanding 
the novel microvessel developing mechanism, monitoring tumor development and 
angiogenesis inhibitors’ therapy effects. The non invasive in vivo angiogenesis imaging 
is achieved through dual modality imaging technique by combining photoacoustic 
tomography (PAT) and NIR fluorescence imaging in this study as described in chapter II. 
PAT provides high resolution structural images of tumor angiogenesis, and fluorescence 
imaging offers high sensitivity to molecular probes for tumor detection. Coregistration 
of the PAT and fluorescence images was used in this study to visualize tumor location, 
angiogenesis, and brain structure simultaneously. In U87 tumor, αvβ3 integrin is a very 
important factor for angiogenesis because it functions as a hook to pull out newly 
developed vessels. Non invasive in vivo mapping of tumor αvβ3 concentration was 
achieved and described in chapter IV.  
 
Hypoxia, an imbalance between oxygen (O2) supply and consumption, is a characteristic 
feature of locally advanced solid tumors. Major causative factors of tumor hypoxia are 
abnormal structure and function of the microvessels supplying the tumor, increased 
diffusion distances between the nutritive blood vessels and the tumor cells, and reduced 
O2 transport capacity of the blood due to the presence of disease- or treatment-related 
anemia. Tumor hypoxia is a therapeutic concern since it can reduce the effectiveness of 
radiotherapy, some O2-dependent cytotoxic agents, and photodynamic therapy. Tumor 
hypoxia can also negatively impact therapeutic outcome by enabling the cells to 
overcome nutritive deprivation or to escape their hostile environment. The study of 
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tumor hypoxia will lead to better methods for studying biological processes as well as 
diagnosing and managing cancer. In chapter III, I present a noninvasive in vivo 
spectroscopic PAT oxygenation measurement technology, which combines high optical 
contrast with high ultrasonic resolution by employing short laser pulses to generate 
acoustic waves in biological tissues. Spectroscopic PAT, which is based on the 
spectroscopic differences among oxygenated hemoglobin and deoxygenated hemoglobin, 
was successfully used to map the total hemoglobin (HbT) concentration and hemoglobin 
oxygen saturation (SO2) in the nude mouse brain intracranial inoculated with U87 
glioblastoma tumor cell line which provides direct information related to tumor 
oxygenation and angiogenesis. 
 
Glucose uptake of malignant glioblastoma tumor can be used to estimate the overall 
metabolic activity since glucose is the primary energy source. It is a very useful factor 
for cancer detection, therapy design and treatment monitoring. In chapter V, fluorescent 
2-deoxyglucose analog, 2-[N-(7-nitrobenz-2-oxa-1,3-diaxol-4-yl)amino]-2-
deoxyglucose (2-NBDG) was used in multiphoton and conventional fluorescence 
imaging for assessing glucose uptake by U87 glioblastoma cells in in vitro culture and 
U87 tumors xenografted into mice respectively.  
 
By virtue of tumor cell enzymes, neoplastic cells can irreversibly drain the host of 
essential amino acids. In chapter VI, amino acid metabolism is evaluated by using free 
amino acid targeting contrast agent Cy 3.5 NHS ester through monitoring the free amino 
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acid concentration. The tumor-bearing animals are in negative energy balance but in 
overall positive nitrogen balance due to the growth of the tumor. They decreased their 
food intake, the energy for the tumor growth is coming from consume body lipids. The 
nitrogen, which was necessary for the proliferation of the tumor, was made available by 
a net breakdown of skeletal muscles. The monitoring amino acid metabolism is very 
important for early cancer detection and future therapy approach. For example, folate 
(One-carbon amino acid) anti-metabolites such as methotrexate were decided to be used 
in cancer chemotherapy after the study of amino acid metabolism. The malignant tumor 
has high rate of proliferation, and hence a high requirement for folate for DNA 
synthesis, but has only very limited reserves. Therefore it is susceptible to the actions of 
anti-metabolites. Alternating therapy with folate anti-metabolites, followed by repletion 
with massive doses of folate, seems to be effective in many cases. In chapter VI, a 
preliminary method to evaluate fast amino acid metabolism by studying free amino acid 
is presented. Multiphoton excitation microscopy with the presence of Cy3.5 N-
hydroxysuccinimide (NHS) ester contrast agent has a potential to be used for non 
invasive in vivo detection for free amino acid metabolism, at least in small animals. 
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CHAPTER II  
TUMOR STRUCTURE AND ANGIOGENESIS 
 
Overview 
 
Here I present a dual modality imaging technique by combining photoacoustic 
tomography (PAT) and near-infrared (NIR) fluorescence imaging for the study of tumor 
in animal model. PAT provides high resolution structural images of tumor angiogenesis, 
and fluorescence imaging offers high sensitivity with the use of molecular probes for 
tumor detection. Coregistration of the PAT and fluorescence images was performed on 
nude mice with subcutaneous M21 human melanoma cells that express αvβ3 integrin 
expression. An integrin αvβ3–targeted peptide–ICG conjugated NIR fluorescent contrast 
agent was used as the molecular probe for tumor detection. PAT was employed for 
noninvasive imaging the brain structures and the angiogenesis associated with tumors. 
Coregistration of the PAT and fluorescence images was used in this study to visualize 
tumor location, angiogenesis, and brain structure simultaneously. 
 
Introduction 
 
The development of noninvasive diagnostic imaging techniques is an area of great 
clinical interest. Such imaging tools are critical for the study of tumor detection and 
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physiology, such as tumor angiogenesis. Photoacoustic tomography (PAT) and near-
infrared (NIR) fluorescence imaging are noninvasive techniques can detect tumors and 
provide complementary structural information about angiogenesis. PAT is an emerging 
imaging modality that takes advantage of both high optical contrast and good ultrasound 
resolution1. Photoacoustic signals are induced by pulsed light illumination. When light 
energy is absorbed by biological tissues, the resulting thermal expansion of the tissues 
generates ultrasonic waves that are detected by an ultrasonic transducer for 
reconstruction of optical absorption distribution inside the tissues. PAT has been shown 
to be a promising tool for biomedical applications, such as the monitoring of 
oxygenation in blood vessels, epidermal melanin measurement, angiography, and breast 
tumor detection2. 
 
In the conventional fluorescence tomography, the efficient light-emitting process is 
triggered by the absorption of the excitation radiation of an appropriate wavelength. The 
fluorescence signal emitted by a molecule or atom after optical excitation can be easily 
detected even in very low concentrations. Light energy is 'packaged' into discreet 
bundles called photons. After fluorophores absorb light of certain wavelengths, their 
electrons transform into an unstable exited state then rapidly lose excess energy and emit 
light. Proper optical filters can be used to distinguish the excitation and emission lights 
since the energy of the emitted light is smaller than the absorbed light which means 
longer wavelength and different color. 
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Fluorescence imaging has high sensitivity, and can also be used to image a variety of 
molecular properties due to its versatile fluorescent probe design 3 , 4 . Fluorescence 
imaging shows strong potential for the diagnostic imaging of tumors. Recently, Li and 
Ke et al. developed an integrin αvβ3–targeted peptide conjugated with indocyanine green 
(ICG) as a fluorescent molecular imaging contrast agent for the noninvasive in vivo 
visualization of M21 human melanoma tumors with αvβ3 integrin expression. Integrin 
αvβ3 plays an important role in tumor angiogenesis and metastasis.5,6 This contrast agent 
was successfully used to identify the M21 tumor in this study due to its αvβ3 targeting 
ability. 
 
Material and Methods 
 
Photoacoustic tomography  
The experimental setup for the in vivo PAT of a nude mouse is shown in Fig. 1.  A 
tunable Ti:Sa nanosecond pulse laser (LT–2211A, Lotis T II, Minsk, Belarus) pumped 
by an Nd:YAG laser (LS–2137/2, Lotis T II, Minsk, Belarus) was employed to provide 
laser pulses with a pulse repetition rate of 10 Hz and a wavelength of 785 nm. The 
incident energy density of the laser beam on the surface of the mouse head was 
controlled to < 2 mJ/cm2. An unfocused ultrasonic transducer (XMS–310, Panametrics) 
with an active element of 2 mm in diameter, a center frequency of 10.4 MHz, and a -6dB 
fractional bandwidth of 100% was used to detect the photoacoustic signals. A computer–
controlled step motor drove the transducer to circularly scan the cortical surface of the 
 9
mouse brain with a radius of 3.5 cm and a step size of 1.5o.  The data acquisition time for 
one image was ~15 minutes. The mouse was fixed by a homemade mount with its head 
protruding into the water tank through a hole in the bottom of the water tank. The hole 
was sealed with a piece of polyethylene membrane. The mouse head surface was 
covered with a thin layer of ultrasonic coupling gel. The detected photoacoustic signals 
were amplified and then digitized by an oscilloscope. The digitized signals were 
transferred to a computer, and the distribution of the optical absorption in the imaging 
plane (x-y plane) was reconstructed using a modified back-projection algorithm after a 
full view scanning. 
 
Amplifier 
Computer 
Oscilloscope 
Step motor 
Water 
tank 
y 
x
z Nd:YAG 
Trigger 
Transducer
Ti:Sa laser
Fixing 
mount 
Concave lens 
Ground glass
 
 
Figure 1.  Experimental setup of in vivo photoacoustic tomography. 
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Near-infrared fluorescence imaging 
Fig. 2 shows the in vivo fluorescence imaging setup for nude mice with a peptide-ICG 
contrast agent. The mouse head was illuminated with light from a laser diode (785 nm, 
80mW) expanded to ~5 cm diameter circular area. A macro lens, coupled to a cooled 
CCD camera (BU401–BR, Andor Technology, CT), collected the emitted fluorescent 
light from the conjugated ICG molecules. The lens was fitted with a holographic notch–
plus filter (785–nm center wavelength, Kaiser Optical Systems, Inc., Ann Arbor, MI) 
and a bandpass filter (830–nm center wavelength). 
Computer
y
x 
z
Fixing 
mount
 Cooled CCD
 Macro Lens 
Emission filter 
 set  Excitation 
filter
LD @ 785 nm
 
Figure 2. Experimental setup of in vivo fluorescence imaging of nude mice with 
peptide–ICG contrast agent. 
 
Cell culture and animal protocols  
All the performed experimental procedures on the M21 tumor cells and mice were 
approved by the University Laboratory Animal Care Committee of Texas A&M 
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University and followed the guidelines of the Guide for the Care and Use of Laboratory 
Animals prepared by the United States National Institutes of Health. 
 
The M21 tumor cell line was maintained in Dulbecco’s modified Eagle’s medium 
(DMEM) (Invitrogen, Carlsbad, CA, USA), supplemented with 10% fetal bovine serum 
(Invitrogen) and antibiotics (100 units/ml penicillin and 100 µg/ml streptomycin).  
 
Nude mice weighing about 20 grams were used for in vivo animal experiments. A dose 
of 87 mg/kg Ketamine plus Xylasine 13 mg/kg, administered intramuscularly, was used 
to anesthetize the mice during the experiments. M21 human melanoma tumor cells were 
inoculated subcutaneously on the head of the nude mice. When the tumor grew to a size 
of about 5 mm diameter, the peptide–ICG conjugated contrast agent was injected, with 
an estimated dosage of 10 µM, into the circulatory system of the mice via tail vein 
injection. The fluorescence and PAT imaging were conducted when the contrast agent 
cleared from blood circulation system which is about 24 hours after the ICG based 
contrast agent injection.  
 
Results and Discussion 
 
Fig. 3(a) shows the NIR fluorescent image of a nude mouse inoculated with a M21 
human melanoma tumor and injected with an integrin αvβ3–targeted peptide–ICG 
conjugated contrast agent. The signal intensity of the tumor region was significantly 
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higher than that of background due to the uptake of the contrast agent by the αvβ3 
integrin receptors. This fluorescence image shows the location and shape of the tumor. 
 
 
(a) 
 
(b) 
 
(c) 
 
(d) 
Feeding 
Vessel 
Figure 3. Tumor detection and tumor angiogenesis imaging results. 
(a) Noninvasive in vivo fluorescence image acquired 24 hours after the ICG 
injection. (b) Noninvasive in vivo PAT image acquired 24 hours after the ICG 
injection with skin and skull intact. (c) Coregistrated noninvasive in vivo image of 
PAT and fluorescence imaging. (d) Open skin and removed skull photograph. 
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Fig. 3(b) is the PAT image. It clearly shows the brain surface vascular system of the 
nude mouse and the structure of the brain. In this experiment, the mouse was fixed on 
the same mount for both the PAT and fluorescence imaging, and the fluorescence 
images were acquired from the top of the mouse head in both cases. Hence, the 
coregistration between the PAT images and fluorescence images is feasible. The 
coregistered image of the PAT and fluorescence imaging is shown in Fig. 3(c). The 
fluorescence image was overlapped on top of the PAT image. Comparing Fig. 3(b) with 
the open skull photograph, Fig. 3(d), we find that the brain structure is well matched 
except for the dashed circled vessel in Fig. 3(b), which is not shown on the surface of the 
brain. Based on the coregistrated image, the vessel marked in Fig. 3(b) is one of the 
major feeding vessels of the tumor. 
 
Conclusion 
 
A dual modality imaging method combining PAT and molecular fluorescence imaging is 
successfully employed to image the angiogenesis of the brain containing a tumor and to 
detect the tumor. A tumor-targeted NIR fluorescent contrast agent is used for the tumor 
detection. By employing coregistration of PAT and fluorescence imaging, the tumor 
location, the tumor angiogenesis, and the brain structure of the nude mouse can be 
visualized at the same time. Future work will focus on molecular PAT imaging using 
spectral information derived from intrinsic and extrinsic molecular contrast.  
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CHAPTER III  
TUMOR SO2 AND HBT DISTRIBUTION MAPPING 
 
Overview 
 
Hypoxia is important in tumor biology and therapy. The study of tumor hypoxia will 
lead to better methods for studying biological processes as well as diagnosing and 
managing cancer. Here we present a noninvasive in vivo spectroscopic photoacoustic 
tomography (PAT) based oxygenation measurement technology, which combines high 
optical contrast and high ultrasonic resolution by employing short laser pulses to 
generate acoustic waves in biological tissues. Spectroscopic PAT, which is based on the 
spectroscopic differences among oxygenated hemoglobin and deoxygenated 
hemoglobin, can be used to map the total hemoglobin (HbT) concentration and 
hemoglobin oxygen saturation (SO2) in the nude mouse brain intracranial inoculated 
with U87 glioblastoma tumor cells which provides direct information related to tumor 
oxygenation and angiogenesis.   
 
Introduction 
 
The brain is notable in its dependence on the blood for its immediate supply of oxygen 
and essential energy substrates. There is a short supply and low levels stored of essential 
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substrates in the brain, this is a very hypoxia vulnerable organ.  An interruption in their 
delivery leads within minutes to irreversible changes resulting in cell death. The brain is 
an organ of high metabolic rate and it is largely dependent on the blood to supply the 
essential fuels for its intense activities. There are clear differences between the in vivo 
metabolic rates of the brains of different mammalian species. Values for cerebral oxygen 
and glucose consumption (the cerebral metabolic rate) in the rat are twice those for the 
dog and three times the values for humans. These data demonstrate the existence of an 
inverse ratio between brain oxygen consumption and body weight that is probably due to 
the relative high neuron-packing density and higher neuron-to-glia ratio in the brain of 
smaller animals.  
  
Cerebral blood oxygenation changes resulting from brain activation are crucial to 
understanding the mechanism of functional cerebral metabolism and pathophysiology. 
Tissue hypoxia occurs where there is an imbalance between oxygen supply and 
consumption. Hypoxia occurs in various pathological conditions including solid tumors 
as a result of an inadequate supply of oxygen, due to exponential cellular proliferation 
and an inefficient vascular supply. 
 
Hypoxia is very important in tumor biology and therapy. Hypoxia inhibits cell 
reproducing and even induces cell death, but it also provides angiogenic and metastatic 
signals which allow prolonged survival in the absence of oxygen and generation of a 
persistent angiogenic signal. Hypoxia stimulates tumor cells' production of acids; the 
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hypoxia and acidity of tumors have important consequences for anti-tumor therapy and 
can contribute to the progression of tumors to a more aggressive metastatic phenotype. 
Recently tumor hypoxia in the malignant potential of cancer cells also has been 
recognized as a physiological stress at a cellular level leading to gene expression in 
normal and tumor tissue.7, 8, 9 Consequently, development of a tumour in the brain with 
demonstrated hypoxia will complicate any therapeutic approach and could result in 
severe impairment of the normal brain homeostasis with negative effects on the host. 
 
The following are samples of the several non-invasive methods currently available for 
measure the oxygenation status of a tumor after decades of efforts. Contrast enhanced 
dynamic computerized tomography (CT)-determined tumor perfusion requires contrast 
agent and cannot provide the most accurate estimate of tumor oxygenation.10, 11 Electron 
paramagnetic resonance (EPR) spectroscopy and imaging techniques have been used to 
determine oxygenation status of tumors 10 mm from the surface of body by using low 
molecular weight stable nitroxide free radical probes which have not yet been fully 
tested in human patients. There are some confounding factors in this method, such as the 
rate of infusion of the probe into the tumor, metabolic reduction of the probe within 
tumor tissue and the clearance of the probe from the tumor tissue by blood flow, etc..12, 
13, 14 Oxygen dependent quenching of phosphorescence is another non-invasive optical 
method for measuring oxygen pressure in tissues. However, this method needs to 
employ phosphors which have not been used in the clinic in human patients and it is 
difficult to obtain a good signal-to-noise-ratio. Since the tumor has a relatively leakier 
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blood vascular system than normal tissue, tumor specific vascular properties will 
interfere with accuracy of tumor oxygenation measurement.15 Oxygen saturation can 
also be measured non-invasively by diffuse light spectroscopy utilizing near-infrared 
(NIR) absorption spectroscopy to measure tissue absorption at two different 
wavelengths. The resolution and accuracy is limited by the light scattering in biological 
tissues while imaging the brain through the intact skin and skull.16, 17 
 
Compare to the above methods, PAT has the ability to image hemoglobin concentration 
and oxygenation simultaneously with high spatial resolution 18  and satisfactory 
penetration depth (~ 5cm)19 in the small animal brain with tumor without using contrast 
agents. Photoacoustic tomography (PAT), employing short laser pulses to generate 
acoustic waves in biological tissues, overcomes both the resolution disadvantage of 
optical imaging and the contrast disadvantages of ultrasonography.20 Spectroscopic PAT 
of imaging the HbT concentration and hemoglobin SO2 in the nude mouse brain 
implanted with human tumor xenograft U87 glioblastoma tumor cell line relies on the 
spectroscopic differences between oxygenated hemoglobin (HbO2) and deoxygenated 
hemoglobin (Hb). In theory, PAT measurements at two wavelengths are sufficient for an 
absolute estimation of brain oxygenation and a relative estimation of blood volume since 
HbO2 and Hb are the dominant absorbers in the mouse brain in the near-infrared (NIR) 
spectral region under study. In order to increase the accuracy of the measurement, four 
wavelengths within the range of 764nm to 824nm are used to make the PAT brain SO2 
measurement overdetermined. Within this range, the penetration depth of light in this 
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range is greater than the size of the imaged brain vessel branches (<50 μm). Meanwhile, 
Hb and HbO2 are the only significant absorbers and scattering was assumed to be 
constant. 
 
Material and Methods 
 
Spectroscopic PAT of HbT and SO2  
Here we explain the principle of spectroscopic PAT using wavelength iλ  within the NIR 
spectra range. The tissue absorption coefficient    (cm–1) can be expressed as )( ia λμ
  ]HbO)[(]Hb)[()( 2HbOHb 2 iiia λελελμ +=
where  and  are the known molar extinction coefficients (cm–1 M–1) of 
Hb and HbO2 at wavelength 
)(Hb iλε )(2HbO iλε
iλ , respectively; 21  and [ ]Hb  and  are the 
concentrations of the two forms of hemoglobin, respectively. Given that the acquired 
localized PA signal 
[ ]2HbO
),,( yxiλφ  is linearly related to the voxel’s absorption coefficient 
after being normalized by the tissue’s optical wavelength-dependent attenuation and the 
incident light energy, one can replace the  by )( ia λμ ), y,( xIλφ  to calculate the [Hb] and 
[HbO2] under multiple wavelength measurements. In principle, two wavelengths are 
enough to determine SO2 from the detected optical absorptions.22 But in order to reduce 
the influence of measurement errors, we used four wavelengths in all of our studies. 
After acquiring the necessary spectroscopic information, least-square fitting gives:  
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The point-by-point SO2 image is therefore calculated as  
 [ ][ ] [ ]HbHbO
HbOSO
2
2
2 +=  
[Hb] ] and  are the molar concentrations of deoxygenated hemoglobin and 
oxygenated hemoglobin, respectively.  
[ 2HbO
 
Experiment setup 
The experimental setup for the in vivo PAT of a nude mouse head is shown in Fig. 4.  A 
tuneable Ti:Sa nanosecond pulse laser (LT–2211A, Lotis T II, Minsk, Belarus) pumped 
by an Nd:YAG laser (LS–2137/2, Lotis T II, Minsk, Belarus) was employed to provide 
laser pulses with a pulse repetition rate of 10 Hz. The laser beam is expanded by a 
concave lens and homogenized by a ground glass and then is delivered to the animal 
head. The incident energy density of the laser beam on the surface of the mouse head 
was controlled to < 3 mJ/cm2 (within the ANSI standard). Each laser pulse’s energy was 
monitored using photodiode (PD) and recorded for normalizing the photoacoustic signal. 
An unfocused ultrasonic transducer (V310/2.25MHz, Panametrics) with 6mm active area 
in diameter is used as the detector to receive the induced acoustic signals. This 
commercial transducer has nominal bandwidths of 50% to 80% of their central 
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frequencies. A computer–controlled step motor drives the transducer to circularly scan 
3mm below the cortical surface of the nude mouse brain with a radius of 3.5 cm and a 
step size of 3 o. 764nm, 784nm, 804nm and 824nm four wavelengths were implemented 
in each scanning step. The mouse is fixed by a homemade restrain mount with its head 
protruding into the water tank through a hole in the bottom of the water tank. The hole 
was sealed with a piece of polyethylene membrane. The mouse head surface is covered 
with a thin layer of ultrasonic coupling gel. The detected photoacoustic signals were 
amplified and then digitized by an oscilloscope. The digitized signals are transferred to a 
computer, and the distribution of the optical absorption in the imaging plane (x-y plane) 
is reconstructed using a modified back-projection algorithm after a full view scanning. 
         
Figure 4. Experimental setup of in vivo spectroscopic photoacoustic tomography for 
small animal. 
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Cell culture and animal protocols 
All the performed experimental animal procedures on the nude mice were approved by 
the University Laboratory Animal Care Committee of Texas A&M University and 
followed the guidelines of the Guide for the Care and Use of Laboratory Animals 
prepared by the United States National Institutes of Health. 
 
U87 glioblastoma tumour cells were used for implantation into young adult 
immunocompromised nude mice (Harlan, Co.). The cell line is maintained in Dulbecco's 
Modified Eagle Medium (DMEM) with 10000 Units/ml Penicillin and 10% Fetal Bovine 
Serum (Gibco, Inc.).  
 
The young adult nude mice weighing about 20 grams were purchased from Harlan, Co., 
IN and used throughout the study. Stereotactic implantation of graft cells, U87 
glioblastoma tumour cells was performed under full anaesthesia using a mixture of 
ketamine, 87 mg/kg (Ketaset, Forth Dodge Animal Health) and xylazine, 13 mg/kg 
(AnaSed, Lloyd Laboratories). The cells (1x106) were inoculated intracranially into the 
caudate nucleus at 3mm depth from the surface with a volume of 7 µl by using a 10 µl 
Hamilton syringe. The nude mouse body temperature was controlled at 37°C using water 
heating pad. The healthy status, pulse rate and the global arterial blood oxygenation, of 
the mouse were monitored through the entire experiment using pulse oximeter (Model 
8600, Nonin Medical, Inc.) which was clamped on the back paw of the nude mouse. U87 
glioblastoma tumor cells were inoculated intracranially at 3mm depth from the surface 
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of the nude mouse head seven days before the PAT experiment. After the experiments, 
the mice were sacrificed to obtain brain tissue sections/slides. After the slides were 
fixed, half of them were stained with Thionine to identify the tumor and the other half 
were stained with anti-von Willebrand Factor viii antibody to demonstrate the tumor-
associated neovascularization.    
 
Results and Discussion 
 
Angiogenesis is very critical in the development of tumors because the blood vessels 
will bring oxygen and nutrients and remove metabolic wastes. Von Willebrand Factor 
(Factor VIII Related Antigen - VWF-VIII) is a widely used endothelial cell markers for 
studying angiogenesis/neovascularization.23 Fig. 5(a) shows the photography of anti-von 
Willebrand Factor antibody stained saggital section of the mouse brain implanted with 
U87 glioblastoma tumor. Fig. 5(b) and (c) are the microscope images (40x mag.) of the 
normal and tumor areas of the brain section which are indicated by characters “b” and 
“c” in Fig. 5(a) respectively. It is clearly that the tumor tissue contains more irregularly 
oriented  blood vessels than normal tissue.  
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Figure 5. Mouse brain section images. 
(a) Photography of anti-von Willebrand Factor viii antibody stained saggital 
section of the mouse brain implanted with U87 glioblastoma tumor; (b) microscope 
image (10x mag.) of tumor area in (a) which is indicated by letter b; (c) microscope 
image (10x mag.) of normal brain area in (a) which is marked by letter c. 
 
To enhance contrast in the normally colorless tissue sections, some tissue sections are 
stained with Thionine which will stain the cell nuclei. Compared to the normal brain 
tissue the brain bearing tumors have more compact basophylic hypercellularity with an 
irregular shape as the circled area shown in Fig. 6(b). Figs. 6(a) and (b) show the tumor 
located at the right side in the brain. Tumor hypoxia was imaged by the spectroscopic 
PAT, as shown in Fig. 6(d). The cortex vessels in Fig. 6(a) can be matched with Fig. 6(c) 
the brain total hemoglobin concentration image. Fig. 6(d) is obtained by masking the 
blood oxygen saturation image with brain total hemoglobin concentration image. Fig. 
6(c) and (d) are acquired seven days after the U87 glioblastoma tumor cells inoculated.  
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Figure 6. PAT and histology images. (a) Photography of a nude mouse brain 
inoculated with U87 glioblastoma tumor; (b) Thionine-stained frozen, saggital 
section of the mouse brain implanted with U87 glioblastoma tumor; (c) the brain 
total hemoglobin concentration image; (d) estimated brain blood oxygen saturation 
image; (c) and (d) are simultaneously obtained from noninvasive in vivo 
spectroscopic PAT; the circles indicate the tumour location, right caudate nucleus 
and cortex. 
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Hypoxia occurred at the circled tumor area in Fig. 6(d) due to structural and functional 
abnormalities of the tumor microvasculature, increased diffusion distances, and tumor-
associated anemia. 
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Figure 7. Average SO2 values of 4 blood vessels obtained by spectroscopic PAT 
from 3 mice. Y axis values of branch 1, 2 and 3 bars are the mean values of SO2 in 
branch blood vessels located on the cortex surface of the nude mice which have 
same topology positions as the blood vessel indicated by arrow “A” in Fig. 3(d). The 
y axis value of 4th bars in 3 groups is the mean value of SO2 in blood vessels which 
have same topology positions as the blood vessel indicated by arrow “B” in Fig. 
3(d). 
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Conclusion 
 
Noninvasive functional imaging and quantification of brain tumor hemoglobin 
concentration and hemoglobin oxygenation through the intact skin and skull with 
satisfactory spatial resolution is a difficult task, yet it is very important parameter in 
underpinning the pathophisiology of tumor development.  
 
There are 3 groups of bars in Fig. 7, each group represents the spectroscopic PAT 
experiment data acquired from one nude mouse. Y axis values of branch 1, 2 and 3 bars 
are the mean values of SO2 in branch blood vessels located on the cortex surface of the 
nude mice which have same topology positions as the blood vessel indicated by arrow 
“A” in Fig. 6(d). The y axis value of 4th bars in 3 groups is the mean value of SO2 in 
blood vessels which have same topology positions as the blood vessel indicated by arrow 
“B” in Fig. 6(d). Obviously the tumor tissue is hypoxia since the SO2 value at tumor 
tissue is lower than the normal brain tissue. From Fig. 7 and Fig. 6, we can conclude that 
spectroscopic PAT can assess point-by-point functional parameters and changes in 
tumor areas in the brain quantitatively with high spatial resolution which will provide 
better understanding of tumor biology and potential use to new approaches for tumor 
therapy. 
 
The absorption, scattering and refractive index of the nude mouse head tissues as 
functions of wavelength which will affect the distribution of optical energy in the head 
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need to be studied in more detail. Spectroscopic PAT three-dimensional functional brain 
imaging should be implemented to improve the depth resolution which will increase the 
accuracy of the measurement. An ultrasonic transducer array should be used to reduce 
the imaging time and make real-time imaging become feasible.  
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CHAPTER IV  
SIMULTANEOUS TUMOR ΑVΒ3 INTEGRIN AND OXYGENATION 
MEASUREMENT 
 
Overview 
 
Here we present simultaneous noninvasive in vivo molecular imaging and tumor 
oxygenation imaging using spectroscopic photoacoustic tomography (PAT), which 
detects absorption spectroscopic differences among molecular targeting contrast agent, 
oxyhemoglobin (O2Hb), and deoxyhemoglobin (HHb). Nude mice brains with 
intracranially implanted glioma tumors were imaged by SPAT after a tumor targeted 
contrast agent was systematic administrated through tail vein. We successfully obtained 
image of the contrast agent distribution around tumor inside mouse brain with high 
spatial resolution, which has been impossible using conventional optical molecular 
imaging modalities because of light scattering. In addition to molecular contrast, SPAT 
visularized the brain oxygenation images in which tumor hypoxia clearly seen. This new 
imaging method can be useful for visualization of various molecular targeting agents and 
its delivery for drug development along with metabolic activities around tumours for 
therapeutic purpose.  
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Introduction 
 
Molecular imaging is the characterization and measurement of biological processes in 
living animals at the cellular and molecular level. The study of molecular imaging will 
lead to better methods for studying complex disease pathways, diagnosing disease at the 
earliest causative stages.  
 
Spectral PAT is a mixed noninvasive imaging modality that takes advantage of both high 
optical contrast and high ultrasound resolution without ionizating radiation.24   Short 
pulse electromagnetic wave in the visible or NIR region irradiates the imaging object to 
generate photoacoustic waves according to the thermoelastic mechanism. The 
distribution of electromagnetic absorption can be reconstructed using the detected 
photoacoustic signals. The absorption spectrum for each reconstructed image element 
was found by changing wavelength of radiation source, and the spatial distribution of 
molecular agent can be extracted by analysing it. Compare to other molecular imaging 
systems, spectral PAT has the ability to image not just the molecular contrast agents 
distribution but also other major absorbers in the simultaneously with high spatial 
resolution (~60 μm)25 and satisfactory penetration depth (~ 5cm)26. In the NIR spectral 
region, these three absorbers inside small animal dominate the photoacoustic signal. 
They are the dominant absorbers in the mouse brain in the NIR spectral region under 
study. Within NIR range, the penetration depth of light in this range is greater than the 
size of the imaged brain vessel branches (<50 μm) within intracranial tumor. Cerebral 
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blood oxygenation changes are crucial to understanding the mechanism of functional 
cerebral metabolism and pathophysiology. Tumor hypoxia is very important in tumor 
biology and therapy. Hypoxia stimulates tumor cells' production of acids; the hypoxia 
and acidity of tumors have important consequences for anti-tumor therapy and can 
contribute to the progression of tumors to a more aggressive metastatic phenotype.27, 28, 
29 SPAT measurements at three wavelengths are sufficient for an absolute estimation of 
the molecular contrast agent distribution, HbT and SO2 since they are the dominant 
absorbers in the mouse brain in the NIR spectral region under study. Within NIR range, 
the penetration depth of light in this range is greater than the size of the imaged brain 
vessel branches (<50 μm).  
 
Material and Methods 
 
Cell culture and animal protocols 
All the performed experimental animal procedures on the nude mice were approved by 
the University Laboratory Animal Care Committee of Texas A&M University and 
followed the guidelines of the Guide for the Care and Use of Laboratory Animals 
prepared by the United States National Institutes of Health. 
 
U87 glioblastoma tumour cells were used for implantation into young adult 
immunocompromised nude mice (Harlan, Co.). The cell line is maintained in Dulbecco's 
Modified Eagle Medium (DMEM) with 10000 Units/ml Penicillin and 10% Fetal Bovine 
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Serum (Gibco, Inc.). Stereotactic implantation of the U87 glioblastoma tumour cells was 
performed on the nude mice weighing about 20 grams under full anaesthesia using a 
mixture of ketamine, 87 mg/kg (Ketaset, Forth Dodge Animal Health) and xylazine, 13 
mg/kg (AnaSed, Lloyd Laboratories). The cells (1x106) were inoculated intracranially 
into the caudate nucleus at 3mm depth from the mouse head surface with a volume of 7 
µl by using a 10 µl Hamilton syringe.  
 
The molecular contrast agent was injected through mouse tail vein with a dosage of 20 
nM per rat. The experiment is conducted 20 hours after the contrast agent administration.  
The nude mouse body temperature was controlled at 37°C using water heating pad. The 
healthy status, pulse rate and the global arterial blood oxygenation, of the mouse were 
monitored through the entire spectroscopic photoacoustic experiment using pulse 
oximeter (Model 8600, Nonin Medical, Inc.) with a detector clamped on the back paw of 
the nude mouse. After the experiments, the mice were sacrificed to obtain brain tissue 
sections/slides. One third of the slides were imaged using Odyssey fluorescence 
microscanner at 800 nm to verify the WW307 uptake. After the other two thirds of slides 
were fixed, half of them were stained with Thionine to identify the tumor, the other half 
were stained with anti-von Willebrand Factor viii antibody to demonstrate the tumor-
associated neovascularization. 
 
Spectroscopic photoacoustic experiments setup 
The experimental setup for the in vivo spectroscopic photoacoustic tomography of a 
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nude mouse head is similar to the one shown in Fig. 4.  A tuneable Ti:Sa nanosecond 
pulse laser (LT–2211A, Lotis T II, Minsk, Belarus) pumped by an Nd:YAG laser (LS–
2137/2, Lotis T II, Minsk, Belarus) was employed to provide laser pulses with a pulse 
repetition rate of 10 Hz. The laser beam was expanded by a concave lens and 
homogenized by a light diffuser and then was delivered to the animal head. The incident 
energy density of the laser beam on the surface of the mouse head was controlled at ~ 
20mJ/cm2 (within the ANSI standard). Each single laser pulse’s energy was monitored 
using photodiode (PD) and recorded for normalizing the photoacoustic signal. Two types 
of ultrasonic transducers (V323/2.25MHz, XMS-310/10MHz, Panametrics) were used as 
the detectors to receive the induced acoustic signals. The diameters of the active areas 
are 6 mm for the 2.25 MHz transducers, 2 mm for the 10 MHz transducer. These 
commercial transducers have nominal bandwidths of 50% to 80% of their central 
frequencies. A computer controlled step motor drove the 10MHz and 2.25MHz 
transducers to circularly scan the nude mouse cortical surface and 3mm below 
respectively the cortical with a radius of 3.5 cm and a step size of 3 degree. Instead of 
three different wavelengths, four different wavelengths (764nm, 784nm, 804nm and 
824nm) were used to increase the measurement accuracy. Photoacoustic signals induced 
by those four wavelengths were obtained in each scanning step to reduce the motion and 
contrast agent bleaching artefacts. The nude mouse was fixed by a homemade restrain 
mount with its head protruding into the water tank through a hole in the bottom of the 
water tank. The hole was sealed with a piece of polyethylene membrane. The mouse 
head surface was covered with a thin layer of ultrasonic coupling gel. The detected 
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photoacoustic signals were amplified and then digitized by an oscilloscope. The 
digitized signals are transferred to a computer, and the distribution of the molecular 
contrast agent and the SO2 in the imaging plane (x-y plane) is calculated and 
reconstructed after a single full view scanning. 
 
Spectroscopic PAT of molecular and SO2 imaging 
A spectroscopic PAT consists of a calculation of the intensity of the acoustic signal 
detected by a piezoelectric detector against the excitation wavelength. The wavelength 
of the excitation laser pulse is varied altering the characteristics of the thermoelastic 
wave due to the wavelength dependent change in the optical properties of the 
chromospheres in the tissue. By analyzing the spectrum, we can investigate important 
properties of varies absorbers in the object, such as concentration, volume, etc. 
20 hours after the molecular contrast agent intravenously administrated into the nude 
mice through the tail vein, there are only three main absorbers (the contrast agent, HHb 
and O2Hb) in the NIR range. Then the tissue absorption coefficient at wavelength λi   
can be calculated as 
μa (λi) = εHHb(λi)[HHb] + εO2Hb(λi)[O2Hb] + εContrastAgent (λi)[ContrastAgent] 
where εHHb(λi), εO2Hb(λi)  andεContrastAgent (λi)are the known molar extinction coefficients 
of HHb, O2Hb and the contrast agent at wavelength iλ , respectively;30 ,  HHb[ ] O2Hb[ ] 
and [ContrastAgent ] are the molar concentrations of hemoglobin, oxy-hemoglobin and 
the molecular contrast agent, respectively. The acquired localized PA signal φ(λi)  is 
linearly related to the voxel’s absorption coefficient after being normalized by the 
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tissue’s optical wavelength-dependent attenuation and the incident light energy, the 
 in the above equation can be replaced by )( ia λμ φ(λi)  to calculate [ContrastAgent ] , 
 and under multiple wavelength measurements. Therefore point-by-point 
images of the molecular contrast agent, HHb and O2Hb distributions can be calculated 
using the PA signals and known molar extinction coefficients. The point-by-point SO2 
image can be calculated as  
HHb[ ] ]O2Hb[
SO2 = O2Hb[ ]O2Hb[ ]+ HHb[ ]  
 
Results and Discussion 
 
The molecular contrast agent we used for the SPAT non-invasive in vivo visualization of 
U87 tumors with αvβ3 integrin expression is an integrin αvβ3-targeted peptide cyclo(Lys-
Arg-Gly-Asp-Phe) [c(KRGDf)] labeled with near infrared fluorescence dye IRDye800-
NHS (LI-COR, Inc.). c(KRGDf) was synthesized using Fmoc solid phase chemistry on 
linker-PL-DMA resin. To conjugate the IRDye800-NHS with c(KRGDf), a mixture of 
IRDye800-NHS (1 eq) and c(KRGDf) (1.3 eq) in dimethylformamide/DIPEA (10/1, v/v) 
was stirred for 24 hours at room temperature. The compound was purified by reverse-
phase HPLC after remove the solvent under vaccum. The product was validated by 
analytic high-performance liquid chromatography (HPLC) and matrix-assisted laser 
desorption ionization (MALDI).  Molecular SPAT imaging of the contrast agent uptake 
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by the U87 glioma tumor has the potential to allow early stage cancer detection, unravel 
the tumor angiogenesis since αvβ3’s presence is greatly increased near neo-angiogenesis. 
 
In Fig. 8 (a), the peptide-dye conjugates (red colour) bound specifically to tumor cells 
(green colour) expressing αvβ3. From Fig. 8 (b), premixed with c(KRGDf) blocked the 
uptake of IRDye800-c(KRGDf) in cell culture because the c(KRGDf) blocked the αvβ3 
receptor of the U87 cells.  
Figure 8. Fluorescence images of U87 cell culture. 
 
(a) 
 
(b) 
(a) 3 minutes after add 6µM molecular contrast agent in the U87 cell culture; (b) 3 
minutes after add 6µM molecular contrast agent in the U87 cell culture which is 
premix with 1.2µM c(KRGDf) for 5 minutes. Both (a) and (b) are fluorescence 
microscope images. 
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Figure 9.  PAT, fluorescence and histology images. 
(a) Thionine stained section photo of the nude mouse brain with U87 tumor; (b) 
Factor-VIII satined section photo; (c) Fluorescence frozen section image of the 
brain acquired by Odyssey fluorescence microscanner; (d) estimated distribution 
of the molecular contrast agent in the brain superimposed on the photoacoustic 
brain structure image; (e) Photography of a nude mouse brain with U87 
glioblastoma tumor; (f) fluorescence image of the nude mouse head superimposed 
on the planar image; estimated brain blood oxygen saturation image. (d) is 
acquired by noninvasive in vivo spectroscopic PAT; (a), (b) and (c) are at the depth 
of ~1 mm from the brain cortex; the doted areas indicate the tumor positions. 
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In vivo fluorescent image (Fig. 9 (f)) was acquired on the same nude mouse before the 
SPAT experiments to verify the molecular contrast agent uptake and compare with the 
molecular SPAT images.  
 
Fig. 9 (a), (b) and (c) show the tumor located at the right side of the brain. Integrin αvβ3–
targeted peptide–ICG conjugated NIR fluorescent contrast agent is injected 
intravenously through the nude mice tail 24 hours before the spectroscopic PAT 
imaging. The contrast agent is bonded with αvβ3 integrin which is over-expressed by 
newly formed tumor microvessels. The fluorescence images in Fig. 9 (c) and (f) indicate 
uptaking of the contrast agent in the tumor area. Fig. 9 (d) shows the contrast agent 
distribution in the brain; it is clearly that the contrast agent is mainly accumulated at the 
tumor area. Since PAT overcomes the resolution disadvantage of optical imaging caused 
by the overwhelming light scattering in biological tissue, the resolution of PAT image 
(d) is higher than the planar fluorescence image (f). Hence, the tumor is more localized 
in Fig. 9 (d). In addition, tumor hypoxia, which is an important parameter in tumor 
therapy, was also imaged by the molecular spectroscopic PAT, as shown in Fig. 10 (a).  
 
There are 3 groups of bars in Fig. 10 (b), each group represents the spectroscopic PAT 
experiment data acquired from one nude mouse. Y axis values of branch 1, 2 and 3 bars 
are the mean values of SO2 in branch blood vessels located on the cortex surface of the 
nude mice which have same topology positions as the blood vessel indicated by arrow 
“A” in Fig. 9(d). The y axis value of 4th bars in 3 groups is the mean value of SO2 in 
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blood vessels which have same topology positions as the blood vessel indicated by arrow 
“B” in Fig. 9(d). Obviously the tumor tissue is hypoxia since the SO2 value at tumor 
tissue is lower than the normal brain tissue. From Fig. 10 and Fig. 9, we can conclude 
that spectroscopic PAT can assess point-by-point functional parameters and changes in 
tumor areas in the brain quantitatively with high spatial resolution which will provide 
better understanding of tumor biology and potential use to new approaches for tumor 
therapy. 
 
 
Figure 10.  Brain tumor oxygen distribution. 
(a) Oxygen saturation image of nude mice brain with U87 tumor; (b) statistical data 
of SO2 in cerebral branch blood vessels and tumor area. 
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Conclusion 
 
During the SPAT experiments, we observed that the maximum molecular contrast agent 
uptake occurred 20 hours after the tail vein administration using in vivo fluorescence 
imaging. The contrast between the tumor tissue and normal tissue is 2:1.  
 
In order to reduce photobleaching, we used shutter to shorten the laser shining time on 
the nude mouse head. We found that even there was photobleaching but the absorption 
bleaching is so small that it can be neglected. Since the SPAT is based on the tissue 
absorption property, the photobleaching effect of the contrast agent has not affect the 
accuracy of the uptake measurement.  
 
We can use more wavelengths and consider more compensation factors to increase the 
accuracy of the contrast agent and SO2 quantification. There is one drawback in the 
current SPAT experimental setup. Real time imaging is not possible since it takes 15 
minutes to obtain one image under single wavelength. Transducer array system should 
be used to achieve fast imaging. This new technology can potentially allow the real time 
detection of cancer in a minimally invasive manner. It could provide immediate 
diagnostic and therapeutic information to the doctors to assist them on treatment plans 
even surgeries. This technology can help reduce morbidity and mortality as well as 
increase survival. 
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CHAPTER V  
TUMOR GLUCOSE METABOLISM 
 
Overview  
 
Glucose uptake in malignant glioblastoma tumor can be used to estimate the overall 
metabolic activity since glucose is the primary energy source. It is a very useful indicator 
for cancer detection, therapy design and treatment monitoring. In this study, fluorescent 
2-deoxyglucose analog, 2-[N-(7-nitrobenz-2-oxa-1,3-diaxol-4-yl)amino]-2-
deoxyglucose, was used  for assessing glucose uptake in U87 glioblastoma cell culture 
and U87 xenograft mice tumors. Multiphoton microscopy images showed that U87 cells 
uptake the glucose analog quickly in the first 8 minutes and then a relatively steady 
concentration is reched. With the presence of D-glucose, the glucose analog uptake was 
significantly decreased. In the retention study, the glucose analog was decayed rapidly in 
the first 10 minutes then slowly degrading and the fluorescence signals remain a certain 
level after 48 minutes. The in vivo fluorescence images of nude mice with U87 
xenograft subcutaneous tumor displayed a maximum uptake at 15 hours after the glucose 
analog was injected intravenously through the tail vein. Due to the malignant 
glioblastoma tumor high glucose metabolic rate, the tumor tissue showed very high 
fluorescence signals compare to the surrounding normal tissue. At 15 hours post 
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injection, glucose was cleared from blood stream, heart, spleen and lung as showed in 
the clearance experiment results. 
 
Introduction 
 
Almost all of the foods we take every day are carbohydrates. The enzymes in the mouth 
and small intestine help to breakdown carbohydrates to make glucose and then absorbed 
into the blood stream. The pancreas insulin regulates the glucose levels in the blood 
stream by unlock/lock the cell’s glucose channels. Insulin molecules bind to their 
associated receptors and promote the uptake of glucose into various tissues that contain 
glucose transporters. Glucose is completely broken down during cellular respiration and 
38 ATP molecules are formed as the primary energy source for cellular work31. Based 
on the existence of a high consumption of glucose and high glycolysis by most tumor 
cells due to an increase in metabolic activity, glucose uptake monitoring can be used for 
cancer detection, therapy development and treatment effectiveness validation .32,33 
 
2-[N-(7-nitrobenz-2-oxa-1,3,diazol-4-yl)amino]-2-deoxyglucose (2-NBDG) is a 
fluorescence glucose analog developed by Yoshioka K., et al. 34 . This fluorescently 
labeled glucose probe can be used as an excellent glucose uptake marker for normal 
nonmalignant cells (bacteria, yeast and mammalian cells) and malignant tumor cells. 2-
NBDG uptake rate has been proved similar to 2-Deoxyglucose (2-DG). Hexokinase 
enzyme phosphorylates the 2-NBDG at the C-6 position after the uptake, thus the 
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glucose analog will be trapped inside the cell35,36. NBD fluorophore group in the 2-
NBDG is sensitive to environment but usually displays intense fluorescence with 
excitation/emission maxima of 465nm/540nm. Previous studies showed that 2-NBDG 
and D-glucose are competing for the glucose transporter to enter the cell which implies 
that 2-NBDG is using same transportation mechanism as glucose37. 
 
Conventional fluorescence tomography was used for in vivo U87 xenograft nude mice 
tumor glucose uptake study using 2-NBDG glucose analog. Fluorescence is an efficient 
light-emitting process that is triggered by the absorption of the excitation radiation of an 
appropriate wavelength. The fluorescence signal emitted by a molecule or atom after 
optical excitation is easily detected even at very low concentrations. Light energy is 
'packaged' into discreet bundles called photons. After fluorophores absorb light of 
certain wavelengths, their electrons transform into an unstable exited state then rapidly 
lose excess energy and emit light. Proper optical filters can be used to distinguish the 
excitation and emission lights since the energy of the emitted light is smaller than the 
absorbed light which means longer wavelength and different color. 
 
In this research, multiphoton excitation microscopy was implemented for monitoring 
U87 glioblastoma tumor cells 2-NBDG uptake and retention. The laser source is sub-10-
Femtosecond pulses and has spectra centered at 800 nm with a full width at half-
maximum (FWHM) of 133 nm. The NBD fluorescent dye is excited at twice the 
wavelength used in ordinary fluorescence observations by absorbing the energy of two 
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photons simultaneously. Since the photon energy is inversely proportional to the 
wavelength, the multiphoton microscopy excitation photon energy is much lower than 
conventional fluorescence imaging.  Because the excitation probability of the fluorescent 
dye in multiphoton excitation is proportional to the square of excitation light intensity, 
only the area proximal to the focal point, where the photon density is high, can be 
excited. Due to the above two reasons, fading of fluorescent dye and damage to tumor 
cells from the excitation light are reduced and limited locally. High 1 micrometer 
resolution is achieved by combining multiphoton excitation with the confocal technique 
in the multiphoton imaging device used for this study38,39. 
 
Material and Methods 
 
Cell culture and animal protocol  
All the performed experimental procedures on the U87 tumor cells and nude mice were 
approved by the University Laboratory Animal Care Committee of Texas A&M 
University and followed the guidelines of the Guide for the Care and Use of Laboratory 
Animals prepared by the United States National Institutes of Health. 
 
U87 glioblastoma tumour cells were used for multiphoton imaging in vitro experiment. 
The cell line was maintained in Dulbecco's Modified Eagle Medium (DMEM) with 
10000 Units/ml Penicillin and 10% Fetal Bovine Serum (Gibco, Inc.). Subcutaneous 
implantation of the U87 tumour cells was performed on the nude mice weighing about 
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20 grams under full anaesthesia using a mixture of ketamine, 87 mg/kg (Ketaset, Forth 
Dodge Animal Health) and xylazine, 13 mg/kg (AnaSed, Lloyd Laboratories). The cells 
(1x106) were inoculated subcutaneously above the medal of skull with a volume of 7 µl 
by using a 10 µl Hamilton syringe. The mice were anaesthetized again for noninvasive 
in vivo fluorescence imaging when the tumor’s diameter reached 5 mm. For the 
multiphoton microscopy experiments, monolayer of U87 cells was attached to the inner 
bottom of a petri dish (35x10 mm) for imaging. A modified balanced salt solution 
(MBSS) was used for washing away nonuptake 2-NBDG from the cells.   
 
The 2-NBDG glucose analog was injected through mouse tail vein with a dosage of 0.1 
mg per mouse when the diameter of the tumor reached 5 mm. The in vivo fluorescence 
imaging experiment was conducted 15 hours after the contrast agent administration.  The 
nude mouse body temperature was controlled at 37°C using water heating pad. After the 
experiments, the mice were sacrificed to obtain various organs’ fluorescence images to 
verify the glucose uptake and clearance.  
 
Multiphoton microscopy 
The light source for the multiphoton microscopy is sub-10-fs pulses from a Kerr-lens 
mode-locked Ti:Al2O3 oscillator (Femtosource Compact, Femtolasers) pumped by a 
frequency-doubles Nd:YVO4 solid-state laser (Verdi, Coherent). The laser light is 
coupled into the epifluorescence port of an upright microscope (Axioskop2 MAT, Zeiss) 
via dual-axis galvanometer driven mirrors (Cambridge Technology) mounted on an 
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elevated breadboard and controlled by a three-axis control board (Vista, ISS). The beam 
is directed to the microscope objective by a short-pass dichroic mirror (635dcspxruv3p, 
Chroma). Nonlinear optical signals are collected by the focusing objective and directed 
to detector unit mounted on an accessory port of the binocular head. Image intensity 
signals are collected and displayed in counts per second on a PC and analyzed by Matlab 
(The MathWorks, Inc., Natick, MA) and Photoshop (Adobe Systems, Inc., San Jose, 
CA). 
 
Fluorescence tomography 
The non invasive in vivo fluorescence imaging setup is similar with the one in figure 2 
for nude mice with 2-NBDG glucose analog contrast agent. The mouse was illuminated 
with light from halogen lamp in a dark chamber filtered by BG25 glass with a 400 nm 
center wavelength. A macro lens, coupled with cooled CCD camera, collected the 
emitted fluorescent light from the 2-NBDG molecules. The lens was fitted with a 
bandpass filter with 540 nm center wavelength. Images were acquired and stored using 
the application that came with the CCD camera. Matlab (The MathWorks, Inc., Natick, 
MA) and Photoshop (Adobe Systems, Inc., San Jose, CA) were used to process and 
analyze the images. 
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Results and Discussion 
 
Multiphoton microscopy study 
 
 
Figure 11. Multiphoton images of U87 cell culture. 
Multiphoton microscopy images of U87 tumor cells obtained 10 minutes after 
adding 0.1 mM 2-NBDG glucose analog (a. 20 Mag.; b. 40 Mag).  
 
10 minutes after 0.1 mM 2-NBDG was added to the petri dish with a monolayer of U87 
cells attached on the inner bottom, the cells were washed in MBSS and multiphoton 
microscopy images were collected (Fig. 11.). In Fig. 11 (b), the glucose analog went 
through the dash circled cell’s membrane and distributed in the cytoplasm but not in the 
cell nucleus. The lower solid line circled cells are in the telophase of mitosis. In this 
phase, the cell’s dividing requires high glucose metabolism rate to produce enough 
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energy especially in perinuclear area due to the graduate reformation of nuclear envelope. 
This is consistent with the multiphoton microscopy image, the glucose analog went 
through the nuclear envelope and the perinuclear area has more condensed 2-NBDG 
signals.  
 
Because the high nanometer resolution and high sensitivity, the multiphoton microscopy 
could be used to detect and monitor molecular level changes. Noninvasive in vivo 
imaging of glucose metabolism is difficult because the optical characteristics of glucose. 
The fluorescence glucose analog 2-NBDG was used as a contrast agent for imaging 
glucose metabolism successfully in this study. By combining the merit of multiphoton 
microscopy and fluorescence glucose analog, high resolution imaging of cell glucose 
activities can be achieved. 
 
The time dependent U87 cells 2-NBDG uptake is shown in Fig. 12. line (a). Three 
minutes after the U87 cells immersed in 0.1 mM 2-NBDG with MBSS, a series of 
multiphoton microscopy images were taken at 10 seconds per frame for 30 minutes. 
Same as Fig. 12 line (c) and (e), each data point on line (a) is the average fluorescence 
signal strength calculated from one multiphoton microscopy image contains about 30 
cells at the specific time point. The data line (a) was made from more than 200 images 
(images are not shown). The lines (b), (d) and (f) are trend lines for the corresponding 
data lines. According to the fluorescence signal strength recorded, the maximum uptake 
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Figure 12. U87 tumor cells glucose metabolism study.  
Using 2-NBDG measured by multiphoton microscopy. X axis is the time course in 
minutes and the Y axis shows the fluorescence signal strength in arbitrary unit. (a) 
Changes of fluorescence signal strength within 37 min. after adding 0.1 mM 2-
NBDG; (b) trend line for (a); (c) Retention of fluorescence signal strength within 48 
min. after incubation for 20 min. with 0.1 mM 2-NBDG; (d) trend line for (c); (e) 
Changes of fluorescence signal strength after adding 0.1 mM 2-NBDG with the 
presence of 5 mM D-glucose; (f) trend line for (e). 
 
occurred at 7.5 minutes then the glucose signal was decayed slowly. To assess the 
glucose retention of U87 cells, the cells in the petri dish were exposed to 0.1 mM 2-
NBDG for 20 minutes, then washed with MBSS and fixed on the multiphoton 
microscope for imaging. The analyzed retention data was shown in Fig. 3. line (c). The 
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fluorescence signals of the glucose analog were decayed quickly during the first 10 
minutes then slowly degrade. Fig. 12. Line (e) is the experiment result for glucose 
analog uptake with the presence of D-Glucose. The U87 cells were exposed to 0.1 mM 
2-NBDG and 5 mM D-Glucose at the same time. Compare the line (e) signal strength 
with line (a) and (c), it showed that the 2-NBDG concentration in the cells is lower due 
to the competition of D-Glucose. This result verified that the 2-NBDG is a valid glucose 
analog since it uses same transportation pathway, glucose transporter (GLUT), as 
glucose.  
 
Based on the data from the above experimental results and the facts that 2-NBDG will be 
phosphorylated and decompose to a non-fluorescence derivative at the C-6 position in 
the cell (Yoshioka, 1996), our study confirmed that the U87 tumor cell dynamic glucose 
metabolism equilibrium can be monitored by the multiphoton microscopy. The glucose 
was uptaken by the U87 cells quickly (~8 minutes) and then saturated at a relatively 
stable state. Without glucose supplement, the glucose was consumed by the U87 cells 
quickly at the first 10 minutes then gradually decomposed overtime. 
 
In vivo fluorescence tomography study 
0.1 mg 2-NBDG in 0.1 mL MBSS was injected through the nude mouse tail vein, the 
noninvasive in vivo fluorescence images were taken every 5 hours for 25 hours (Data is 
not shown). The maximum tumor fluorescence signal strength was detected at 15 hours 
after the 2-NBDG injection as showed in Fig. 13. after coregistered with white image. 
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The tumor region on the mouse head has significantly strong fluorescence signal 
intensity compare to the background due to the fact that the malignant U87 tumor has 
high glucose metabolism which consistent with the characteristic of malignant tumors. 
 
 
Figure 13. Nude mouse with U87 subcutaneous tumor noninvasive in vivo 
fluorescence image. Coregistered with white image obtained 15 hours after 0.1 mg 
2-NBDG tail vein injection. 
 
Another set of control nude mice were sacrificed 15 hours after the 2-NBDG 
administration for 2-NBDG clearance study. The fluorescence images of various 
tissue/organ were taken as showed in Fig. 14. The tumors have strong fluorescence 
signal compare to other organs such as intestines, kidney and liver. The heart, blood, 
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spleen and lung did not have any fluorescence signals which implied that the glucose 
analog already has been cleared out from these blood stream and organs. 
 
 
Figure 14. Fluorescence images and white images of dissected nude mouse 
organs/tissues. (lung, intestine, kidney, heat with blood, liver, spleen, tumors) 
obtained 15 hours after 2-NBDG tail vein injection. 
 
Conclusion 
 
Our preliminary study showed that by combining multiphoton microscopy and in vivo 
fluorescence imaging using 2-NBDG glucose analog, both the U87 cell activities and 
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whole tumor glucose metabolism can be successfully studied in cell culture and live 
animal. 
 
This demonstrates the possibilities to use multiphoton microscopy and fluorescence 
imaging technique with the assistance of fluorescence glucose analog to study glucose 
metabolism. In the future, we will study the multiphoton microscopy glucose imaging 
using multiple wavelengths at the same time with various fluorescence glucose analogs. 
Noninvasive in vivo nanometer resolution live animal multiphoton imaging will be 
implemented to study the tumor glucose metabolism in details.    
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CHAPTER VI  
TUMOR CELL AMINO ACID METABOLISM 
 
Overview 
 
The abnormal amino acid metabolism and protein synthesis are very common in cancer 
patients. Neoplastic cells can irreversibly consume the essential amino acids from the 
cancer host due to the nature of tumor cell enzymes. The monitoring amino acid 
metabolism is very important for cancer detection, cancer development monitoring, 
therapy design and evaluation of the therapy effects. Ion exchange chromatography or 
specially adapted reverse phase-high performance liquid chromatography (RP-HPLC) to 
evaluate tumor tissue free amino acid is a popular application for tissue biopsy to study 
the amino acid and protein metabolism. These methods are time consuming and also 
cannot be done in vivo even in experimental animals. In this study, a novel preliminary 
method is presented for studying free amino acid, which also has the potential to be used 
for experimental animals in vivo. With the presence of free amino acid targeted Cy 3.5 
NHS ester, the free amino acid distributions were showed clearly by acquired 
multiphoton tomography images in (N-ethyl-N-nitrosourea) ENU (not mammary 
carcinoma) cell culture and by in vivo fluorescence images in live rat bearing ENU 
tumor xerograph.   
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Introduction 
 
The fate of amino acids and their metabolism can be conveniently grouped under three 
paths. First, protein synthesis utilizes amino acids as the basic materials in all tissue. 
Second, amino acids are precursors for the synthesis of various nitrogenous small 
molecules. Third, amino acids in excess of requirements degrade and eventually form 
urea exclusively in the liver40. 
 
Disorders of amino acid metabolism are among the most common of the inborn errors of 
human metabolism which are defects that arise from abnormal protein synthesis. The 
abnormal amino acid metabolism and protein synthesis can also be found in cancer 
carriers. By virtue of tumor cell enzymes, neoplastic cells can irreversibly drain the host 
of essential amino acids41. 
 
The tumor-bearing animals were in negative energy balance but in overall positive 
nitrogen balance due to the growth of the tumor. The food intake decrease and the body 
lipids, which provide the energy for the tumor growth, are gradually exhausted and the 
animals with tumor become cacotrophia. The nitrogen, which was necessary for the 
proliferation of the tumor, was made available by a net breakdown of skeletal muscles. 
Muscle protein turnover accounts for a significant proportion of whole body protein 
turnover. Therefore, any reduction in muscle turnover is a suitable way to save energy 
and to channel amino acids toward protein synthesis and gluconeogenesis elsewhere42.  
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The monitoring amino acid metabolism is very important for cancer detection, cancer 
develop monitoring, therapy design and evaluation of the therapy effects. For example, 
folate (One-carbon amino acid) anti-metabolites such as methotrexate were decided to be 
used in cancer chemotherapy after the study of amino acids metabolism. The tumor has 
high rate of proliferation, and hence a high requirement for folate for DNA synthesis, but 
has only very limited reserves. Alternating therapy with folate anti-metabolites, followed 
by repletion with massive doses of folate, seems to be effective in many cases43.  
 
In this study, I present a novel preliminary method for fast evaluate amino acid 
metabolism by studying free amino acid. This method has the potential to be used on 
experimental animals in vivo. Multiphoton excitation microscopy and in vivo 
conventional fluorescence tomography with the presence of Cy3.5 N-
hydroxysuccinimide (NHS) ester contrast agent were used in this method. 
 
Multiphoton excitation microscopy is a technique that uses non-linear optical 
effects to achieve optical sectioning. The sample is illuminated with a wavelength 
around twice the wavelength of the absorption peak of the fluorophore being used. For 
example, in the case of fluorescein which has an absorption peak around 500nm, 1000 
nm excitation could be used. Essentially no excitation of the fluorophore will occur at 
this wavelength. However, if a high peak-power, pulsed laser is used (so that the mean 
power levels are moderate and do not damage the specimen), two-photon events will 
occur at the point of focus. At this point the photon density is sufficiently high that two 
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photons can be absorbed by the fluorophore essentially simultaneously. This is 
equivalent to a single photon with energy equal to the sum of the two that are absorbed. 
In this way, fluorophore excitation will only occur at the point of focus (where it is 
needed) thereby eliminating excitation of out-of-focus fluorophore and achieving optical 
sectioning. 
 
Material and Methods 
 
Cell culture and animal protocol  
All the performed experimental procedures on the N-ethyl-N-nitrosourea (ENU) tumor 
cells and rats were approved by the University Laboratory Animal Care Committee of 
Texas A&M University and followed the guidelines of the Guide for the Care and Use of 
Laboratory Animals prepared by the United States National Institutes of Health. 
Chemicals and solutions were obtained from Sigma Chemical Co.(St. Louis, MO, USA) 
unless otherwise indicated. 
 
The ENU1564 tumor cell line used in this study was originally developed in our 
laboratory and originated from an N-ethyl-N nitrosourea-induced mammary 
adenocarcinoma in a female Berlin-Druckrey IV (BD-IV) rat. This cell line is highly 
metastatic to brain and bone tissues (30). Prior to imaging experiments, the cell line was 
maintained in Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen, Carlsbad, 
CA, USA), supplemented with 10% fetal bovine serum (Invitrogen) and antibiotics (100 
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units/ml penicillin and 100 µg/ml streptomycin). For the multiphoton microscopy 
experiments, monolayer of ENU cells was attached to the inner bottom of a petri dish 
(35x10 mm) for imaging. A modified balanced salt solution (MBSS) was used to wash 
the cells since DMEM will give strong background fluorescence signals.  
 
Cy3.5 NHS ester (GE Healthcare Bio-Sciences, Piscataway, NJ, USA) 
 
 
Figure 15. Diagram for NHS ester binding mechanism.  
The most convenient and widely used functional group for the labelling of biological 
molecules is a primary amino group. This can be provided by the e-amino group of a 
lysine residue, or the free N-terminus of a peptide/protein. Alternatively, it is possible to 
introduce primary amine containing modifier groups during automated synthesis of, for 
example, oligonucleotides. Stable active esters of flora labelling species that may be 
stored as solid materials, in particular NHS ester, have been extensively used over many 
years for the acylation of such amino groups, as shown in the reaction schematic in 
figure 15. 
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Multiphoton microscopy 
Multiphoton microscopy setup was as same as mentioned in chapter V. The laser source 
is sub-10-Femtosecond pulses and has spectra centered at 800nm with a full width at 
half-maximum (FWHM) of 133 nm. The Cy3.5 NHS ester fluorescent dye is excited at 
twice the wavelength used in ordinary fluorescence observations by absorbing the 
energy of two photons simultaneously. The excitation peak of Cy3.5 dye is around 
550nm and emission peak is around 590nm as showed in figure 16. Since 500nm-550nm 
is within the bandwidth of our multiphoton imaging setup, with a 590nm emission filter 
Cy3.5 dye fluorescence signal can be acquired. 
 
 
Figure 16. Excitation (blue line) and emission (red line) spectra of Cy3.5 dye. 
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Results and Discussion 
 
Multiphoton microscopy study 
Twenty minutes after 0.3 mM Cy3.5 NHS ester was added to the petri dish with a 
monolayer of ENU cells attached on the inner bottom, the cells were washed in MBSS 
and multiphoton microscopy images were collected (Fig. 17.). The dark spots in the 
middle of the cells are nucleolus inside cell nuclei. The high multiphoton signal (darker 
color) indicates high amino acid concentration. This is consistent with the fact the amino 
acid concentration in nucleolus is high since messenger RNA (mRNA) is translated from 
DNA (deoxyribonucleic acid) in the nucleolus of cells. The three white spots in figure 17 
are dead ENU cells. Because Cy3.5 NHS ester does not label the dead cells, we can 
conclude that the dead cells lost the ability to transport the contrast agents through the 
cell membrane.    
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Figure 17. Multiphoton image of ENU cells.  (40 Mag.)20 Minutes after 0.3mM 
Cy3.5 NHS ester Uptake.  
 
Because the high nanometer resolution and high sensitivity, the multiphoton microscopy 
could be used to detect and monitor molecular level changes. Imaging of amino acid 
metabolism is difficult because of the optical characteristics of amino acid. It is invisible 
to the imaging systems which can only detect visible light wavelength. The fluorescence 
Cy3.5 NHS ester was used as a contrast agent for imaging amino acid metabolism 
successfully in this study. Due to the strong fluorescence signal emitted from Cy3.5 
NHS ester, this contrast agent can be used for non invasive in vivo imaging study.   
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Figure 18. ENU cells dye uptake study. 
Using Cy3.5 NHS ester by multiphoton microscopy. Changes of fluorescence signal 
strength within 20 minutes after adding 0.3 mM Cy3.5 NHS ester. X axis is the time 
course in minutes and the Y axis shows the fluorescence signal strength in arbitrary 
unit.  
 
The time dependent ENU cells Cy3.5 NHS ester uptake is shown in figure 18. Three 
minutes after the ENU cells immersed in 0.3 mM Cy3.5 NHS ester with MBSS, a series 
of multiphoton microscopy images were taken at 10 seconds per frame for 20 minutes. 
Each data point is the average fluorescence signal strength per pixel per cell calculated 
from one multiphoton microscopy image contains about 10 cells at the specific time 
point. The data was collected from more than 120 images (images are not shown). The 
black line is average trend line for the corresponding data points. According to the 
 62
fluorescence signal strength recorded, the maximum uptake occurred at 14 minutes then 
the Cy3.5 NHS ester signal remained relatively constant.  
 
In figure 19, concentration dependent ENU cells Cy3.5 NHS ester uptake is shown. 
Twenty minutes after the ENU cells immersed in 0.3, 0.2, 0.1 mM Cy3.5 NHS ester with 
MBSS, a series of multiphoton microscopy images were taken at 10 seconds per frame 
for 40 minutes. Same as in figure 18, each data point is the average fluorescence signal 
strength per pixel per cell calculated from one multiphoton microscopy image contains 
about 10 cells at the specific time point. The data was collected from more than 240 
images (images are not shown). The black lines are trend lines for the corresponding 
data lines. From the data presented in figure 19, it shows that the multiphoton signal 
strength is not only related to amino acid concentrations distribution in the ENU cells 
but also related to the Cy3.5 NHS ester concentration used. So if this technique will be 
used to quantify the amino acid distribution, the contrast agent concentration must be 
considered.  
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Figure 19. ENU cell free amino acid metabolism study. 
Using Cy3.5 NHS ester with different concentrations. a) trend line for blue data line 
which was collected 20 minutes after ENU cell immersed in 0.3 mM Cy3.5 NHS 
ester; b) trend line for green data line which was collected 20 minutes after ENU 
cell immersed in 0.2 mM Cy3.5 NHS ester; c) trend line for green data line which 
was collected 20 minutes after ENU cell immersed in 0.1 mM Cy3.5 NHS ester. 
 
 64
 
Figure 20. ENU cells and C1 astrocytes free amino acid metabolism study. 
Using Cy3.5 NHS ester. Images was collected 20 minutes after cells immersed in 0.1 
mM Cy3.5 NHS ester.  
 
In figure 20, ENU cells and immortalized murine C1 astrocytes Cy3.5 NHS ester uptake 
is shown. Twenty minutes after the cells immersed in 0.1 mM Cy3.5 NHS ester with 
MBSS, a series of multiphoton microscopy images were taken at 10 seconds per frame 
for 20 minutes. The y axis values are the average fluorescence signal strength per pixel 
per cell calculated from multiphoton microscopy images. The immortalized astrocytic 
line was developed from the cerebral cortex and brain stem of FVB/N mice infected with 
a retrovirus carrying the gene of the tsA58 T antigen by Dr. Wong’s group in M.D. 
Anderson Cancer Center, University of Texas. From the data presented in figure 20, it 
shows that the ENU cell line has almost 2 times higher amino acid concentration 
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comparing to C1 astrocytes. This is due to the aggressive metabolism characteristic of 
the ENU tumor cells.  
 
Conclusion 
 
Our preliminary study showed that by implementing multiphoton microscopy using 
Cy3.5 NHS ester contrast agent, amino acid metabolism can be successfully studied in 
ENU cell culture. This method will at least lead to a relative concentration map of amino 
acid in cells which can be used as an indicator for protein metabolism in tumor. Non 
invasive in vivo imaging can be achieved by modifying the current multiphoton imaging 
device. 
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CHAPTER VII  
SUMMARY AND CONCLUSION 
 
In chapter II, M21 human melanoma tumor detection is successfully achieved by dual 
modality imaging method combining PAT and molecular fluorescence imaging. Nude 
mice M21 brain subcutaneous tumor angiogenesis was studied. A tumor-targeted NIR 
fluorescent contrast agent is used for the tumor detection. By employing coregistration 
of PAT and fluorescence imaging, the tumor location, the tumor angiogenesis, and even 
the brain surface histology structure of the nude mouse were revealed at the same time.  
 
In chapter III and IV, non invasive functional molecular spectroscopic PAT imaging and 
quantification of brain tumor hemoglobin concentration and hemoglobin oxygenation 
through the intact skin and skull with satisfactory spatial resolution was presented. 
Tumor tissue hypoxia was observed at the same time when αvβ3 integrin distribution in 
brain tumor was measured as described in chapter IV. This study verified that 
spectroscopic PAT can be used to map point-by-point functional parameters and changes 
in tumor areas in the brain quantitatively with high spatial resolution. This will provide 
better understanding of tumor biology and potential use to new approaches for tumor 
therapy. This new technology can be further modified to accommodate real time 
detection of cancer in a minimally invasive manner. It could provide immediate 
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diagnostic and therapeutic information to the doctors to assist them on treatment plans 
even surgeries. This technology can help reduce morbidity and mortality of patients. 
 
In chapter V, the preliminary study showed that by combining multiphoton microscopy 
and in vivo fluorescence imaging using 2-NBDG glucose analog, both the U87 tumor 
cell culture and in vivo nude mice brain tumor glucose metabolisms can be successfully 
evaluated. This demonstrates the possibilities to use multiphoton microscopy and 
fluorescence imaging technique with the assistance of fluorescence glucose analog to 
study glucose metabolism.  
 
The monitoring of amino acid metabolism is very important for cancer detection, cancer 
development monitoring and therapy design. Chapter VI showed that by implementing 
multiphoton microscopy using Cy3.5 NHS ester contrast agent, tumor amino acid 
metabolism can be successfully studied in cell culture. This method will at least give you 
a relative concentration map of amino acid in cells. Non invasive in vivo imaging can be 
achieved by modifying the current multiphoton imaging setup. 
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